American Healthcare REIT Inc

The stock is in a Stage 2 advancing regime with intact medium- and long-term uptrends, but short-term momentum has softened as price pulls back into the 20-day EMA and 50-day SMA confluence on low volume. Execution is deferred until clear support acceptance emerges near these moving averages.

• ↑Q2 2026 NFFO at $0.54 per share, up 28.6% YoY
• ↑Raised full-year NFFO guidance to $2.15–2.19 per diluted share
• ↓Negative earnings yield suggests valuation may be stretched